106 related articles for article (PubMed ID: 11783506)
21. Clinical trials referral resource. Clinical trials with 2-chlorodeoxyadenosine.
Cheson BD
Oncology (Williston Park); 1992 May; 6(5):95-8. PubMed ID: 1350917
[No Abstract] [Full Text] [Related]
22. Induction of apoptosis by 2-chloro-2'deoxyadenosine (2-CdA) alone and in combination with other cytotoxic drugs: synergistic effects on normal and neoplastic lymphocytes by addition of doxorubicin and mitoxantrone.
Chow KU; Rummel MJ; Weidmann E; Ries J; Jantschke P; Boehrer S; Pourebrahim F; Napieralski S; Stein J; Martin H; Hoelzer D; Mitrou PS
Leuk Lymphoma; 2000 Feb; 36(5-6):559-67. PubMed ID: 10784401
[TBL] [Abstract][Full Text] [Related]
23. 2-Chlorodeoxyadenosine in the treatment of multiple myeloma.
Dimopoulos MA; Kantarjian HM; Estey EH; Alexanian R
Blood; 1992 Sep; 80(6):1626. PubMed ID: 1355673
[No Abstract] [Full Text] [Related]
24. Bilateral facial nerve palsy as first indication of relapsing hairy cell leukemia after 36 years.
Ferrari J; Lang W; Thurnher S; Müllauer L; Raderer M
Neurology; 2004 Jul; 63(2):399-400. PubMed ID: 15277655
[No Abstract] [Full Text] [Related]
25. Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro.
Ganeshaguru K; Wickremasinghe RG; Jones DT; Gordon M; Hart SM; Virchis AE; Prentice HG; Hoffbrand AV; Man A; Champain K; Csermak K; Mehta AB
Haematologica; 2002 Feb; 87(2):167-76. PubMed ID: 11836167
[TBL] [Abstract][Full Text] [Related]
26. 2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society.
Weitzman S; Braier J; Donadieu J; Egeler RM; Grois N; Ladisch S; Pötschger U; Webb D; Whitlock J; Arceci RJ
Pediatr Blood Cancer; 2009 Dec; 53(7):1271-6. PubMed ID: 19731321
[TBL] [Abstract][Full Text] [Related]
27. Tumor lysis syndrome after treatment of chronic lymphocytic leukemia with cladribine.
Trendle MC; Tefferi A
N Engl J Med; 1994 Apr; 330(15):1090. PubMed ID: 8127350
[No Abstract] [Full Text] [Related]
28. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.
Piro LD; Carrera CJ; Carson DA; Beutler E
N Engl J Med; 1990 Apr; 322(16):1117-21. PubMed ID: 1969613
[TBL] [Abstract][Full Text] [Related]
29. 2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia.
Santana VM; Mirro J; Kearns C; Schell MJ; Crom W; Blakley RL
J Clin Oncol; 1992 Mar; 10(3):364-70. PubMed ID: 1346800
[TBL] [Abstract][Full Text] [Related]
30. 2-Chlorodeoxyadenosine (cladribine)-related eosinophilia in patients with lymphoproliferative diseases.
Robak T; Błasińska-Morawiec M; Krykowski E; Hellmann A; Lewandowski K; Dmoszyńska A; Adamczyk-Cioch M; Kazimierczak M; Trepińska E; Dwilewicz-Trojaczek M; Kuratowska Z; Skotnicki AB; Nowak WS; Zdziarska B; Urasiński I
Eur J Haematol; 1997 Oct; 59(4):216-20. PubMed ID: 9338619
[TBL] [Abstract][Full Text] [Related]
31. Retreatment of chronic lymphocytic leukemia with 2-chlorodeoxyadenosine (CdA) at relapse following CdA-induced remission: no acquired resistance.
Juliusson G; Liliemark J
Leuk Lymphoma; 1994 Mar; 13(1-2):75-80. PubMed ID: 8025525
[TBL] [Abstract][Full Text] [Related]
32. 2-chloro-2'-deoxyadenosine: clinical applications in hematology.
Delannoy A
Blood Rev; 1996 Sep; 10(3):148-66. PubMed ID: 8932828
[TBL] [Abstract][Full Text] [Related]
33. Phase I study of combined 2-chlorodeoxyadenosine and chlorambucil in chronic lymphoid leukemia and low-grade lymphoma.
Tefferi A; Witzig TE; Reid JM; Li CY; Ames MM
J Clin Oncol; 1994 Mar; 12(3):569-74. PubMed ID: 8120555
[TBL] [Abstract][Full Text] [Related]
34. Mycophenolate mofetil for severe autoimmune haemolytic anemia.
Zimmer-Molsberger B; Knauf W; Thiel E
Lancet; 1997 Oct; 350(9083):1003-4. PubMed ID: 9329520
[No Abstract] [Full Text] [Related]
35. Synthesis and induction of apoptosis in B cell chronic leukemia by diosgenyl 2-amino-2-deoxy-beta-D-glucopyranoside hydrochloride and its derivatives.
Myszka H; Bednarczyk D; Najder M; Kaca W
Carbohydr Res; 2003 Jan; 338(2):133-41. PubMed ID: 12526837
[TBL] [Abstract][Full Text] [Related]
36. A phase I clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemia.
Santana VM; Mirro J; Harwood FC; Cherrie J; Schell M; Kalwinsky D; Blakley RL
J Clin Oncol; 1991 Mar; 9(3):416-22. PubMed ID: 1671875
[TBL] [Abstract][Full Text] [Related]
37. Profound toxicity of deoxyadenosine and 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo.
Carrera CJ; Yamanaka H; Piro LD; Lotz M; Carson DA
Adv Exp Med Biol; 1989; 253B():219-25. PubMed ID: 2575348
[TBL] [Abstract][Full Text] [Related]
38. The purine analogs--a therapeutic beauty contest.
Cheson BD
J Clin Oncol; 1992 May; 10(5):868-71. PubMed ID: 1349035
[No Abstract] [Full Text] [Related]
39. Low dose 2-CdA schedule activity in splenic marginal zone lymphomas.
Riccioni R; Caracciolo F; Galimberti S; Cecconi N; Petrini M
Hematol Oncol; 2003 Dec; 21(4):163-8. PubMed ID: 14735554
[TBL] [Abstract][Full Text] [Related]
40. The purine analogs--a therapeutic beauty contest.
Cheson BD
J Clin Oncol; 1992 Mar; 10(3):352-5. PubMed ID: 1346799
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
